These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563 [TBL] [Abstract][Full Text] [Related]
8. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789 [TBL] [Abstract][Full Text] [Related]
9. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054 [TBL] [Abstract][Full Text] [Related]
10. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496 [TBL] [Abstract][Full Text] [Related]
11. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249 [TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184 [TBL] [Abstract][Full Text] [Related]
16. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Farin HM; Abbasi F; Reaven GM Am J Cardiol; 2006 Oct; 98(8):1053-6. PubMed ID: 17027570 [TBL] [Abstract][Full Text] [Related]
17. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Halvorsen B; Lund Sagen E; Ueland T; Aukrust P; Tonstad S Scand J Clin Lab Invest; 2007; 67(6):604-11. PubMed ID: 17852807 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Miyazaki Y; DeFronzo RA Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983 [TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Winkelmann BR; Boehm BO; Nauck M; Kleist P; März W; Verho NK; Ranjith N; Kneissl G Curr Med Res Opin; 2001; 17(2):132-41. PubMed ID: 11759183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]